Evidence map›Paper›PMID 35540456›Full record

ArticleRSC advances2018

Biodegradable copolypeptide hydrogel prodrug accelerates dermal wound regeneration by enhanced angiogenesis and epithelialization.

Anqi Chen, Huacheng He, Guanglong Ma, Yi Li, Shishuang Jiang, Xuan Xuan, Yi Song, Cuiyun Zhang, Jian Xiao, Yunsheng Xu and 2 more

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Anqi ChenThe First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000 P. R. China xuyunsheng1018@163.com.
Huacheng HeWenzhou University Wenzhou 325035 P. R. China hehc@wzu.edu.cn.ORCID https://orcid.org/0000-0001-5177-0636
Guanglong MaZhejiang University Hangzhou 310027 P. R. China.
Yi LiWenzhou Medical University Wenzhou 325035 P. R. China woody870402@hotmail.com.
Shishuang JiangWenzhou Medical University Wenzhou 325035 P. R. China woody870402@hotmail.com.
Xuan XuanWenzhou Medical University Wenzhou 325035 P. R. China woody870402@hotmail.com.
Yi SongWenzhou Medical University Wenzhou 325035 P. R. China woody870402@hotmail.com.
Cuiyun ZhangWenzhou Medical University Wenzhou 325035 P. R. China woody870402@hotmail.com.
Jian XiaoWenzhou Medical University Wenzhou 325035 P. R. China woody870402@hotmail.com.
Yunsheng XuThe First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000 P. R. China xuyunsheng1018@163.com.
Jiang WuThe First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000 P. R. China xuyunsheng1018@163.com.
Shengfu ChenZhejiang University Hangzhou 310027 P. R. China.
Wenzhou University · CNHangzhou Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogels are one of the most promising wound dressings. However, their effectiveness on wound healing is still largely limited due to either the non-degradability or the release of non-therapeutic degradable products. Herein, a biodegradable copolypeptide hydrogel based on the glutamic acid and lysine was synthesized and applied as both wound dressing and therapeutic prodrug. The hydrogel can degrade in the existence of elevated degradative enzymes in a wound environment, which will release therapeutic amino acids to enhance the wound healing.

Identifiers

PMID35540456
PMCPMC9078897
OpenAlexW2792386352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.